Related references
Note: Only part of the references are listed.Long-Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long-Term Extension of the BENEFIT Study
L. Rostaing et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Randomized Controlled Trial of Sirolimus Conversion in Cardiac Transplant Recipients With Renal Insufficiency
A. Zuckermann et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation - PROTECT
L. Fischer et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Ten-Year Outcome after Rapid Discontinuation of Prednisone in Adult Primary Kidney Transplantation
Michael D. Rizzari et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation
Sylvie Euvrard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Switching from Calcineurin Inhibitor-based Regimens to a Belatacept-based Regimen in Renal Transplant Recipients: A Randomized Phase II Study
Lionel Rostaing et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial
Matthew R. Weir et al.
KIDNEY INTERNATIONAL (2011)
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial
Klemens Budde et al.
LANCET (2011)
Everolimus Plus Reduced-Exposure CsA versus Mycophenolic Acid Plus Standard-Exposure CsA in Renal-Transplant Recipients
H. Tedesco Silva et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Calcineurin Inhibitor Minimization in the Symphony Study: Observational Results 3 Years after Transplantation
H. Ekberg et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Delayed Introduction of Reduced-Dose Tacrolimus, and Renal Function in Liver Transplantation: The 'ReSpECT' Study
J. M. Neuberger et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Immunosuppressive Drugs in Kidney Transplantation Impact on Patient Survival, and Incidence of Cardiovascular Disease, Malignancy and Infection
Roberto Marcen
DRUGS (2009)
Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation
A. S. R. Muthusamy et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
2202 kidney transplant recipients with 10 years of graft function:: What happens next?
A. J. Matas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Late kidney allograft loss: What we know about it, and what we can do about it
Anthony M. Jevnikar et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Reduced exposure to calcineurin inhibitors in renal transplantation
Henrik Ekberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Chronic kidney disease after nonrenal solid-organ transplantation
Roy D. Bloom et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Two years postconversion from a Prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients
Rita Alloway et al.
TRANSPLANTATION (2007)
Mycophenolate mofetil/sirolimus compared to other common immunosuppressive regimens in kidney transplantation
T. R. Srinivas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: The CAESAR study
H. Ekberg et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era
HU Meier-Kriesche et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years
SM Flechner et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients
HJ Eisen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study
BD Kahan
LANCET (2000)
Share Paper
